Beranda068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩160.500,00
Rentang hari
₩160.200,00 - ₩163.400,00
Rentang tahun
₩150.400,00 - ₩200.952,39
Kapitalisasi pasar
36,28 T KRW
Volume Rata-Rata
460,25 rb
Rasio P/E
61,82
Hasil dividen
0,44%
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (KRW) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 841,91 M | 14,24% |
Biaya operasional | 293,45 M | 0,76% |
Laba bersih | 108,67 M | 384,28% |
Margin laba bersih | 12,91 | 324,67% |
Penghasilan per saham | 529,00 | 414,31% |
EBITDA | 220,36 M | 49,86% |
Tarif pajak efektif | 44,58% | — |
Neraca
Total aset
Total liabilitas
| (KRW) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 970,72 M | 5,45% |
Total aset | 20,96 T | 4,00% |
Total liabilitas | 3,68 T | 16,94% |
Total ekuitas | 17,28 T | — |
Saham yang beredar | 224,61 jt | — |
Harga terhadap nilai buku | 2,10 | — |
Tingkat pengembalian aset | 1,78% | — |
Tingkat pengembalian modal | 1,90% | — |
Arus Kas
Perubahan kas bersih
| (KRW) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 108,67 M | 384,28% |
Kas dari operasi | 113,45 M | 206,45% |
Kas dari investasi | -54,86 M | -55,15% |
Kas dari pembiayaan | -243,49 M | -242,88% |
Perubahan kas bersih | -167,36 M | -191,58% |
Arus kas bebas | 226,51 M | 169,09% |
Tentang
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Didirikan
2002
Situs
Karyawan
2.391
